Fanttest’s 2026 exhibition at the Queen Sirikit National Convention Center (QSNCC) in Bangkok successfully concluded on July 10. Over the three-day event at Booth J.28, we had the opportunity to connect with hundreds of global distributors, medical professionals, and industry partners, showcasing our localized, reliable, and comprehensive IVD testing solutions tailored to the Southeast Asian market.
Addressing the key challenges of regional public health management, Fanttest presented three core product lines covering tropical infectious disease screening, multiple respiratory diseases combo tests, and our newly launched 2026 specialized screening portfolio, including STI, UTI, and DOA testing. All products are independently developed and manufactured by Fanttest, offering stable performance and full regulatory compliance while effectively addressing Southeast Asia’s climate conditions, diverse medical settings, and evolving market needs.
This exhibition marks another significant step forward in Fanttest’s strategic expansion across the ASEAN region. Looking ahead, we will continue to build on our strengths in R&D innovation, standardized manufacturing, and localized services; further optimize our regional supply chain; and develop long-term, mutually beneficial partnerships with global clients. Together, we aim to contribute to the high-quality development of the IVD industry across Southeast Asia.
